Targeted therapy gives cancer patients hope for better survival rates

Targeted therapy gives cancer patients hope for better survival rates

Although HER2-positive breast cancer patients are expected to have lower survival rates compared to those with HER2-negative disease, in this day and age, receiving a diagnosis of metastatic HER2-positive breast cancer is no longer a death sentence.

(Visited 5 times, 1 visits today)
3
Like
Save

Comments

Write a comment